Gino Villetti
Pharmacology And Toxicology Department Corporate Pre Clinical R&D
Parma, Italy
Parma, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 83 publications
From Airways to Arteries: Dissecting the Inflammatory Mechanisms of Pulmonary Vascular Remodeling in a Murine Model of Chronic Airway Inflammation.
Journal: Biomedicines
Published: April 15, 2026
Longitudinal microcomputed tomography uncovers divergent trajectories of lung maturation in preterm and hyperoxia-exposed neonatal rabbits.
Journal: American journal of respiratory cell and molecular biology
Published: December 24, 2025
SPECT as a translational non-invasive method to assess occupancy of the tissue transglutaminase-2 by zampilimab in the mouse lung.
Journal: Respiratory research
Published: December 04, 2025
Design, Synthesis, and Biological Evaluation of the Novel Neutrophil Elastase Inhibitor CHF-6333 for the Inhaled Treatment of Bronchiectasis.
Journal: Journal of medicinal chemistry
Published: November 27, 2025
Label-free optical fingerprints of hyperoxia-induced lung alterations in preterm rabbits.
Journal: Respiratory research
Published: July 28, 2025
Caffeine Protects Newborn Rat Lungs Against the Effects of Hyperoxia and Intra-Amniotic Enterotoxin.
Caffeine Protects Newborn Rat Lungs Against the Effects of Hyperoxia and Intra-Amniotic Enterotoxin.
Journal: Pediatric pulmonology
Published: June 11, 2025
Spatial transcriptomic and morpho-functional information derived from single mouse FFPE slides allows in-depth fingerprinting of lung fibrosis.
Journal: Respiratory research
Published: February 25, 2025
Longitudinal transcriptomic analysis of the hyperoxia-exposed preterm rabbit as a model of BPD.
Journal: Frontiers in pediatrics
Published: January 26, 2025
Transcriptomic analysis reveals lipid metabolism and macrophage involvement associated with nintedanib treatment in a rat bleomycin model.
Journal: British journal of pharmacology
Published: December 10, 2024
Discovery of CHF-6523, an Inhaled Selective PI3Kδ Inhibitor for the Treatment of Chronic Obstructive Pulmonary Disease.
Journal: Journal of medicinal chemistry
Published: December 05, 2024
Novel Cyclohexyl Amido Acid Antagonists of Lysophosphatidic Acid Type 1 Receptor for the Treatment of Pulmonary Fibrosis.
Journal: ACS medicinal chemistry letters
Published: November 21, 2024
Last Updated: 09/26/2026